Stratasys Inc (ISRAEL) (SSYS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Mar 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SSYS SEC filings page.
Stratasys Inc (ISRAEL) (SSYS) reported $551.1M in revenue for fiscal year 2025, down 3.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The business is using cost reduction to narrow operating losses, while reinvestment and external financing remain central to cash management.
Gross margin compression from44.9% in FY2024 to41.2% in FY2025 means the narrower operating loss was not driven by better unit economics. It instead reflected lower SG&A and R&D, pointing to expense control rather than fixed-cost absorption.
FY2025 produced operating cash flow of
The balance sheet’s liability burden declined as total liabilities fell to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Stratasys Inc (ISRAEL)'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Stratasys Inc (ISRAEL) has an operating margin of -13.2%, meaning the company loses $13 on every $100 of revenue. This results in a profitability score of 36/100. This is up from -15.0% the prior year.
Stratasys Inc (ISRAEL)'s revenue declined 3.7% year-over-year, from $572.5M to $551.1M. This contraction results in a growth score of 13/100.
Stratasys Inc (ISRAEL) carries a low D/E ratio of 0.27, meaning only $0.27 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 71/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 3.57, Stratasys Inc (ISRAEL) holds $3.57 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 84/100.
While Stratasys Inc (ISRAEL) generated $15.1M in operating cash flow, capex of $22.1M consumed most of it, leaving -$7.0M in free cash flow. This results in a low score of 19/100, reflecting heavy capital investment rather than weak cash generation.
Stratasys Inc (ISRAEL) posts a -12.4% return on equity (ROE), meaning it loses $12 for every $100 of shareholders' equity. This results in a returns score of 37/100. This is up from -15.2% the prior year.
Stratasys Inc (ISRAEL) scores -0.42, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($762.0M) relative to total liabilities ($230.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Stratasys Inc (ISRAEL) passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Stratasys Inc (ISRAEL) reported a net loss of $104.3M while generating $15.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Stratasys Inc (ISRAEL) generated $140.0M in revenue in Q4 2025. This represents a decrease of 6.9% from the same quarter a year earlier. Against the prior quarter it is up 2.2%.
Stratasys Inc (ISRAEL)'s EBITDA was -$9.6M in Q4 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1787.0% from the same quarter a year earlier. Against the prior quarter it is up 20.0%.
Stratasys Inc (ISRAEL) reported -$18.9M in net income in Q4 2025. This represents an increase of 55.1% from the same quarter a year earlier. Against the prior quarter it is up 66.1%.
Not reported for Q4 2025.
Cash & Balance Sheet
Stratasys Inc (ISRAEL) recorded an outflow of $1.8M in free cash flow in Q4 2025, representing a cash shortfall after capex. This represents a decrease of 157.2% from the same quarter a year earlier. Against the prior quarter it is down 174.1%.
Stratasys Inc (ISRAEL) held $94.5M in cash as of Q4 2025; long-term debt is not reported for that period.
Not reported for Q4 2025.
Margins & Returns
Stratasys Inc (ISRAEL)'s gross margin was 36.8% in Q4 2025, indicating the percentage of revenue retained after direct costs. This is down 9.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.2 percentage points.
Stratasys Inc (ISRAEL)'s operating margin was -14.8% in Q4 2025, reflecting core business profitability. This is down 8.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.8 percentage points.
Stratasys Inc (ISRAEL)'s net profit margin was -13.5% in Q4 2025, showing the share of revenue converted to profit. This is up 14.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 27.2 percentage points.
Stratasys Inc (ISRAEL)'s ROE was -2.2% in Q4 2025, measuring profit generated per dollar of shareholder equity. This is up 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.3 percentage points.
Capital Allocation
Stratasys Inc (ISRAEL) invested $18.0M in research and development in Q4 2025. This represents a decrease of 27.3% from the same quarter a year earlier. Against the prior quarter it is down 12.3%.
Stratasys Inc (ISRAEL) invested $6.6M in capex in Q4 2025, funding long-term assets and infrastructure. This represents an increase of 57.5% from the same quarter a year earlier. Against the prior quarter it is up 48.9%.
Not reported for Q4 2025.
SSYS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q3'256-K | Q2'256-K | Q1'2510-Q | Q4'2420-F | Q3'246-K | Q2'246-K | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $140.0M-6.9% | $137.0M-2.2% | $138.1M0.0% | $136.0M-5.6% | $150.4M-3.8% | $140.0M-13.6% | $138.0M-13.6% | $144.1M-3.6% |
| Cost of Revenue | $88.5M+9.8% | $80.9M+4.7% | $78.6M+1.4% | $75.8M-5.4% | $80.7M-6.8% | $77.3M-19.9% | $77.5M-17.1% | $80.2M-4.6% |
| Gross Profit | $51.5M-26.2% | $56.1M-10.6% | $59.5M-1.7% | $60.2M-5.7% | $69.7M-0.1% | $62.7M-4.4% | $60.5M-8.6% | $63.9M-2.3% |
| R&D Expenses | $18.0M-27.3% | $20.6M-16.8% | $19.9M-22.4% | $18.8M-21.6% | $24.8M-1.2% | $24.7M+4.8% | $25.7M+5.7% | $24.0M+11.7% |
| SG&A Expenses | $54.2M-0.8% | $58.2M-8.3% | $56.2M-7.7% | $53.9M-16.3% | $54.6M+40.0% | $63.5M-25.2% | $60.9M-19.5% | $64.4M+6.0% |
| Operating Income | -$20.8M-114.0% | -$22.7M+10.8% | -$16.6M+36.2% | -$12.4M+49.3% | -$9.7M-271.0% | -$25.5M+40.5% | -$26.0M+22.6% | -$24.5M-45.6% |
| EBITDA | -$9.6M-1787.0% | -$12.0M+15.2% | -$6.0M+58.4% | -$1.6M+86.6% | $570K-96.7% | -$14.2M+52.7% | -$14.5M+30.8% | -$12.2M-138.2% |
| Income Tax | $1.1M+62.6% | $524K-37.8% | $1.0M+36.6% | $455K-36.5% | $653K+2.5% | $842K+30.5% | $762K+5.1% | $716K-81.0% |
| Net Income | -$18.9M+55.1% | -$55.6M-109.0% | -$16.7M+35.0% | -$13.1M+49.8% | -$41.9M-180.4% | -$26.6M+43.7% | -$25.7M+33.3% | -$26.0M-16.9% |
| EPS (Basic) | -$0.22+62.7% | -$0.65-75.7% | -$0.20+44.4% | -$0.18+51.4% | -$0.59-181.0% | -$0.37+45.6% | -$0.36+35.7% | -$0.37-12.1% |
| Diluted Shares (Avg) | N/A | 85M+19.5% | 83M+18.0% | 72M+2.8% | N/A | 71M+3.2% | 71M | 70M |
Not reported in any period shown, so not listed: Interest Expense, EPS (Diluted).
SSYS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q3'256-K | Q2'256-K | Q1'2510-Q | Q4'2420-F | Q3'246-K | Q2'246-K | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B+4.3% | $1.1B+0.4% | $1.1B+5.3% | $1.0B-7.0% | $1.0B-9.2% | $1.1B-8.4% | $1.1B-12.1% | $1.1B-11.1% |
| Current Assets | $582.0M+13.5% | $603.7M+16.2% | $614.8M+17.3% | $507.6M-6.4% | $513.0M-8.4% | $519.3M-11.0% | $524.0M-14.2% | $542.1M-18.5% |
| Cash & Equivalents | $94.5M+34.7% | $71.5M+11.7% | $71.1M+0.3% | $70.1M-23.1% | $70.2M-15.0% | $64.0M-38.8% | $70.9M-50.9% | $91.1M-56.4% |
| Short-Term Investments | $150.0M+86.3% | $0 | $0 | $0 | $80.5M+0.6% | $0 | $0 | $0 |
| Inventory | $145.2M-19.2% | $159.3M-18.4% | $164.6M-16.2% | $169.9M-12.9% | $179.8M-6.8% | $195.2M-1.1% | $196.5M-7.0% | $195.1M-3.4% |
| Accounts Receivable | $160.5M+4.9% | $151.3M-1.5% | $157.9M+4.9% | $156.2M+0.5% | $153.0M-11.1% | $153.7M-6.4% | $150.5M-3.7% | $155.3M+7.5% |
| Long-Term Investments | $61.8M+50.4% | $46.1M-61.6% | $44.2M-63.7% | $43.4M-62.7% | $41.1M-12.9% | $120.1M-7.5% | $121.8M-12.2% | $116.3M-17.3% |
| Goodwill | $101.6M+2.5% | $101.5M+1.4% | $101.6M+2.4% | $99.5M+0.3% | $99.1M-1.0% | $100.1M+11.0% | $99.2M+6.7% | $99.1M+42.1% |
| Total Liabilities | $230.9M-2.5% | $234.7M-6.5% | $236.6M+2.2% | $238.3M+1.9% | $236.8M-4.9% | $250.9M-16.0% | $231.4M-24.7% | $233.9M-20.1% |
| Current Liabilities | $163.0M-2.5% | $165.2M-2.5% | $166.0M+0.8% | $168.1M-0.1% | $167.2M-5.2% | $169.4M-15.5% | $164.7M-21.1% | $168.2M-16.8% |
| Non-Current Liabilities | $67.8M-2.5% | $69.4M-14.8% | $70.6M+5.7% | $70.2M+6.9% | $69.5M-4.3% | $81.5M-17.0% | $66.8M-32.1% | $65.7M-27.4% |
| Total Equity | $842.9M+6.3% | $852.5M+2.5% | $902.4M+6.1% | $784.8M-9.4% | $793.0M-10.4% | $831.8M-5.8% | $850.5M-7.9% | $866.1M-8.3% |
| Retained Earnings | -$2.4B-4.5% | -$2.4B-5.6% | -$2.4B-4.4% | -$2.3B-4.8% | -$2.3B-5.5% | -$2.3B-4.3% | -$2.3B-5.3% | -$2.2B-6.0% |
Not reported in any period shown, so not listed: Long-Term Debt.
SSYS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q3'256-K | Q2'256-K | Q1'2510-Q | Q4'2420-F | Q3'246-K | Q2'246-K | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.8M-35.0% | $6.9M+254.7% | -$1.1M+54.4% | $4.5M-38.1% | $7.4M+195.6% | -$4.5M+65.0% | -$2.4M+89.5% | $7.3M+140.9% |
| Depreciation & Amortization | $11.1M+8.5% | $10.7M-5.3% | $10.6M-8.2% | $10.8M-12.2% | $10.3M-12.8% | $11.3M-12.2% | $11.5M-9.1% | $12.3M+5.0% |
| Stock-Based Compensation | N/A | $5.6M-14.2% | $6.1M-16.4% | $6.2M-28.2% | N/A | $6.6M-12.2% | $7.3M-8.4% | $8.6M+5.0% |
| Capital Expenditures | $6.6M+57.5% | $4.5M+139.2% | $7.3M+193.9% | $3.8M+61.1% | $4.2M-11.2% | $1.9M-18.0% | $2.5M-12.2% | $2.3M-37.4% |
| Free Cash Flow | -$1.8M-157.2% | $2.5M+138.8% | -$8.4M-70.7% | $789K-84.3% | $3.2M+125.5% | -$6.3M+57.9% | -$4.9M+81.1% | $5.0M+123.1% |
| Investing Cash Flow | $18.2M+672.8% | -$6.5M-190.4% | -$119.9M-611.7% | -$4.1M-315.2% | $2.4M+116.0% | -$2.2M+91.3% | -$16.8M+57.1% | $1.9M-97.5% |
| Financing Cash Flow | -$311K+85.9% | -$1K+99.8% | $118.1M+13442.8% | $200K+8.7% | -$2.2M-408.8% | -$415K-3.2% | -$885K+42.4% | $184K-78.5% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
SSYS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q3'256-K | Q2'256-K | Q1'2510-Q | Q4'2420-F | Q3'246-K | Q2'246-K | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.8%-9.6pp | 40.9%-3.9pp | 43.1%-0.8pp | 44.3%-0.1pp | 46.4%+1.7pp | 44.8%+4.3pp | 43.8%+2.4pp | 44.4%+0.6pp |
| Operating Margin | -14.8%-8.4pp | -16.6%+1.6pp | -12.0%+6.8pp | -9.1%+7.9pp | -6.5%-10.1pp | -18.2%+8.2pp | -18.9%+2.2pp | -17.0%-5.7pp |
| Net Margin | -13.5%+14.4pp | -40.6%-21.6pp | -12.1%+6.5pp | -9.6%+8.4pp | -27.9%-18.3pp | -19.0%+10.2pp | -18.6%+5.5pp | -18.0%-3.2pp |
| Return on Equity | -2.2%+3.1pp | -6.5%-3.3pp | -1.9%+1.2pp | -1.7%+1.3pp | -5.3%-3.6pp | -3.2%+2.1pp | -3.0%+1.1pp | -3.0%-0.6pp |
| Return on Assets | -1.8%+2.3pp | -5.1%-2.7pp | -1.5%+0.9pp | -1.3%+1.1pp | -4.1%-2.8pp | -2.5%+1.5pp | -2.4%+0.8pp | -2.4%-0.6pp |
| Current Ratio | 3.57+0.5x | 3.65+0.6x | 3.70+0.5x | 3.02-0.2x | 3.07-0.1x | 3.07+0.2x | 3.18+0.3x | 3.22-0.1x |
| Debt-to-Equity | 0.270.0x | 0.280.0x | 0.260.0x | 0.300.0x | 0.300.0x | 0.300.0x | 0.27-0.1x | 0.270.0x |
| Asset Turnover | 0.130.0x | 0.130.0x | 0.120.0x | 0.130.0x | 0.150.0x | 0.130.0x | 0.130.0x | 0.130.0x |
| FCF Margin | -1.3%-3.4pp | 1.8%+6.3pp | -6.1%-2.5pp | 0.6%-2.9pp | 2.1%+10.1pp | -4.5%+4.7pp | -3.6%+12.8pp | 3.5%+18.0pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Stratasys Inc (ISRAEL) SSYS | FY2025 | $551.1M | -$104.3M | -18.9% | $762.0M | 43/100 |
| Corsair Gaming, Inc. CRSR | FY2025 | $1.5B | $16.0M | 1.1% | $1.5B | 38/100 |
| Cricut, Inc. CRCT | FY2025 | $708.8M | $76.7M | 10.8% | $1.4B | 49/100 |
| Canaan Inc. CAN | FY2025 | $529.7M | -$210.3M | -39.7% | $252.5M | 48/100 |
| Unusual Machines, Inc. UMAC | FY2025 | $11.2M | -$19.2M | N/A | $1.1B | 46/100 |
| Nano Dimension Ltd. NNDM | FY2025 | $102.4M | -$293.3M | N/A | $341.6M | 62/100 |
Where Stratasys Inc (ISRAEL) Ranks
Frequently Asked Questions
What is Stratasys Inc (ISRAEL)'s annual revenue?
Stratasys Inc (ISRAEL) (SSYS) reported $551.1M in total revenue for fiscal year 2025. This represents a -3.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Stratasys Inc (ISRAEL)'s revenue growing?
Stratasys Inc (ISRAEL) (SSYS) revenue declined by 3.7% year-over-year, from $572.5M to $551.1M in fiscal year 2025.
Is Stratasys Inc (ISRAEL) profitable?
No, Stratasys Inc (ISRAEL) (SSYS) reported a net income of -$104.3M in fiscal year 2025, with a net profit margin of -18.9%.
What is Stratasys Inc (ISRAEL)'s EBITDA?
Stratasys Inc (ISRAEL) (SSYS) had EBITDA of -$29.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Stratasys Inc (ISRAEL)'s gross margin?
Stratasys Inc (ISRAEL) (SSYS) had a gross margin of 41.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Stratasys Inc (ISRAEL)'s operating margin?
Stratasys Inc (ISRAEL) (SSYS) had an operating margin of -13.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Stratasys Inc (ISRAEL)'s net profit margin?
Stratasys Inc (ISRAEL) (SSYS) had a net profit margin of -18.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Stratasys Inc (ISRAEL)'s return on equity (ROE)?
Stratasys Inc (ISRAEL) (SSYS) has a return on equity of -12.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Stratasys Inc (ISRAEL)'s free cash flow?
Stratasys Inc (ISRAEL) (SSYS) recorded an outflow of $7.0M in free cash flow during fiscal year 2025. This represents a -128.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Stratasys Inc (ISRAEL)'s operating cash flow?
Stratasys Inc (ISRAEL) (SSYS) generated $15.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Stratasys Inc (ISRAEL)'s total assets?
Stratasys Inc (ISRAEL) (SSYS) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Stratasys Inc (ISRAEL)'s capital expenditures?
Stratasys Inc (ISRAEL) (SSYS) invested $22.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Stratasys Inc (ISRAEL) spend on research and development?
Stratasys Inc (ISRAEL) (SSYS) invested $77.3M in research and development during fiscal year 2025.
What is Stratasys Inc (ISRAEL)'s current ratio?
Stratasys Inc (ISRAEL) (SSYS) had a current ratio of 3.57 as of fiscal year 2025, which is generally considered healthy.
What is Stratasys Inc (ISRAEL)'s debt-to-equity ratio?
Stratasys Inc (ISRAEL) (SSYS) had a debt-to-equity ratio of 0.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Stratasys Inc (ISRAEL)'s return on assets (ROA)?
Stratasys Inc (ISRAEL) (SSYS) had a return on assets of -9.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Stratasys Inc (ISRAEL)'s P/E ratio?
Stratasys Inc (ISRAEL) (SSYS) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $762.0M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Stratasys Inc (ISRAEL)'s price-to-sales ratio?
Stratasys Inc (ISRAEL) (SSYS) trades at 1.4x sales, its market capitalization divided by revenue of $551.1M revenue, FY2025. The market capitalization is $762.0M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Stratasys Inc (ISRAEL)'s Altman Z-Score?
Stratasys Inc (ISRAEL) (SSYS) has an Altman Z-Score of -0.42, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Stratasys Inc (ISRAEL)'s Piotroski F-Score?
Stratasys Inc (ISRAEL) (SSYS) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Stratasys Inc (ISRAEL)'s earnings high quality?
Stratasys Inc (ISRAEL) (SSYS) reported a net loss of $104.3M while generating $15.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Stratasys Inc (ISRAEL)?
Stratasys Inc (ISRAEL) (SSYS) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.